Fermion specializes in AI-enabled drug discovery and modalities for identifying small molecule drugs to progress towards Phases 1 and 2 clinical trials
Here at Fermion, we integrate several cutting-edge technologies across AI, Biology, medicinal chemistry and medicine to develop innovative drug therapies. Our use of advanced techniques such as deep learning, reinforcement learning, generative adversarial networks, big data, and knowledge graphs helps us enhance drug development. This strategy will ultimately lead to refined preclinical research and offer superior treatment options for a variety of diseases. Read More
Read More
AI technology is breaking new ground in drug development,
expanding possibilities
and boundaries